SMR 2019: Encorafenib + Binetinib Under Evaluation for Brain Metastasis of BRAF V600-Mutant Melanoma
Intracranial antitumor activity of the combination was observed in a related study.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.